Amrize AG (AMRZ) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows strong technical indicators, positive analyst sentiment, and moderate growth potential, making it a suitable choice for long-term holding.
The technical indicators are bullish. The MACD is positive and expanding, RSI is neutral at 65.902, and moving averages are aligned bullishly (SMA_5 > SMA_20 > SMA_200). The stock is trading near its resistance level of 57.19, with support at 55.439.

Analysts have consistently raised price targets, with the most recent targets ranging from $66 to $76, citing improved growth prospects and multiple expansion.
Q4 2025 results showed a slight increase in net income (2.41% YoY) and EPS (1.89% YoY), indicating profitability improvements.
The company has announced its Q1 2026 financial results date, which could act as a near-term catalyst.
Revenue dropped slightly (-0.35% YoY) in Q4 2025, and gross margin declined by 1.83% YoY, indicating some operational challenges.
No significant hedge fund or insider trading trends were observed, suggesting a lack of strong institutional conviction.
In Q4 2025, revenue slightly declined (-0.35% YoY) to $2.839 billion. However, net income increased by 2.41% YoY to $298 million, and EPS rose by 1.89% YoY to 0.54. Gross margin decreased to 26.77% (-1.83% YoY), reflecting some cost pressures.
Analysts are overwhelmingly positive on AMRZ, with multiple firms raising price targets recently. The consensus is bullish, with price targets ranging from $66 to $76, supported by improved growth prospects, shareholder yield, and guidance exceeding expectations.